Stay updated on Evaluating Therapeutic HSV-2 Vaccine Formulation Clinical Trial
Sign up to get notified when there's something new on the Evaluating Therapeutic HSV-2 Vaccine Formulation Clinical Trial page.

Latest updates to the Evaluating Therapeutic HSV-2 Vaccine Formulation Clinical Trial page
- Check5 days agoChange DetectedThe ClinicalTrials.gov page’s footer revision identifier changed from v3.8.0 to v3.8.1.SummaryDifference0.1%

- Check12 days agoChange DetectedThe ClinicalTrials.gov study record for the GEN-003 HSV-2 vaccine trial is now available, with details on its completed Phase 2 design, participant criteria, study locations, and outcome measures.SummaryDifference54%

- Check19 days agoChange DetectedThe site revision identifier in the footer changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check33 days agoChange DetectedA site-wide NIH notice about the terminology transition appears above the error page, and the site revision label changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check47 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1. The study record page continues to display a 403 Forbidden message.SummaryDifference0.2%

- Check61 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study record. This indicates access is blocked to the NCT02515175 page rather than any update to the study content.SummaryDifference19%

Stay in the know with updates to Evaluating Therapeutic HSV-2 Vaccine Formulation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Evaluating Therapeutic HSV-2 Vaccine Formulation Clinical Trial page.